Skip to main content
Explore URMC



Andrew G. Evans, M.D., Ph.D.


Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Research Labs

Calvi Lab (affiliate member)

Visit Lab Website

Research Network

URMC Hematopathology Fellowship

Visit Lab Website

Research Network


Professional Background

Dr. Evans is an Assistant Professor of Pathology and Laboratory Medicine, and the Hematopathology Fellowship Program Director. He serves as an attending physician specializing in Hematopathology at Strong Memorial Hospital, and is a Wilmot Cancer Research Fellow at the Wilmot Cancer Institute. He earned his M.D. and Ph.D. degrees from Emory University School of Medicine, and completed his residency and fellowship at Brigham and Women's Hospital, Harvard Medical School, and the Dana Farber Cancer Institute. He is board certified in both Anatomic Pathology and Hematopathology by the American Board of Pathology. Prior to his doctoral studies he earned a bachelor's degree in biology from the University of Chicago, and spent a year doing research at the National Institutes of Health.
Dr. Evans' clinical responsibilities include the diagnostic evaluation of blood, bone marrow, lymph nodes, and other tissues for hematologic and other malignancies. This includes histopathologic and flow cytometric evaluation, along with interpretation of molecular and cytogenetic testing.


My graduate work in immunology and molecular virology focused on the mechanisms by which chronic viruses modulate the host immune response, and how these interactions contribute to lymphoproliferative disorders and other chronic diseases. Current research focuses on the molecular, genetic, and immunologic mechanisms that underlie leukemia and lymphoma development. Specifically, which microenvironmental interactions influence the development and persistence of these diseases. Other interests include the role of chronic viruses in lymphoma development, and the genetic characteristics that influence diagnosis and treatment of pre-myeloid leukemias or myelodysplastic syndromes.


Faculty Appointments


  • Anatomic Pathology - American Board of Pathology
  • Hematopathology - American Board of Pathology


BA | University of Chicago

PhD | Emory University

MD | Emory University School of Medicine

Post-doctoral Training & Residency

7/1/2009 - 6/30/2010
Internship in Pathology-Anatomic and Clinical at Brigham and Women's Hospital

7/1/2010 - 6/30/2012
Residency in Pathology-Anatomic and Clinical at Brigham and Women's Hospital

7/1/2012 - 6/30/2013
Fellowship in Pathology-Anatomic and Clinical at Brigham and Women's Hospital

VIEW ALL expand_more


Journal Articles

Evans AG, Ahmad A, Burack WR, Iqbal MA. "Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2016 Oct 0; 29(10):1183-99. Epub 2016 Jul 08.

Balderman SR, Li AJ, Hoffman CM, Frisch BJ, Goodman AN, LaMere MW, Georger MA, Evans AG, Liesveld JL, Becker MW, Calvi LM. "Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome." Blood.. 2016 Feb 4; 127(5):616-25. Epub 2015 Dec 04.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL. "Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells." British journal of haematology.. 2015 Jun 18; Epub 2015 Jun 18.

Books & Chapters

Chapter Title: Chapter 102: Burkitt Lymphoma
Book Title: Williams Hematology, 9th Edition
Author List: Andrew G. Evans and Jonathan W. Friedberg
Published By: McGraw-Hill2015